Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN\LINAGLIPTIN for Type 1 diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN\LINAGLIPTIN was used for Type 1 diabetes mellitus.

Most Reported Side Effects for EMPAGLIFLOZIN\LINAGLIPTIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 149 9.2% 3 121
Blood glucose increased 121 7.5% 1 15
Fungal infection 92 5.7% 0 3
Weight decreased 77 4.8% 4 10
Nausea 68 4.2% 3 26
Dizziness 58 3.6% 0 10
Vomiting 55 3.4% 3 34
Urinary tract infection 52 3.2% 4 18
Euglycaemic diabetic ketoacidosis 49 3.0% 2 34
Dehydration 44 2.7% 2 26
Ketoacidosis 43 2.7% 5 28
Pollakiuria 34 2.1% 0 3
Glycosylated haemoglobin increased 32 2.0% 0 3
Headache 32 2.0% 0 5
Pancreatitis 32 2.0% 0 16

Other Indications for EMPAGLIFLOZIN\LINAGLIPTIN

Type 2 diabetes mellitus (676) Product used for unknown indication (661) Diabetes mellitus (213) Blood glucose increased (8) Diabetes mellitus management (6)

Other Drugs Used for Type 1 diabetes mellitus

INSULIN LISPRO (9,401) INSULIN GLARGINE (6,569) INSULIN ASPART (3,913) INSULIN HUMAN (2,150) INSULIN DEGLUDEC (1,459) INSULIN DETEMIR (794) INSULIN GLULISINE (569) DEVICE (495) CANAGLIFLOZIN (422) EMPAGLIFLOZIN (383)

Related Pages

EMPAGLIFLOZIN\LINAGLIPTIN Full Profile All Type 1 diabetes mellitus Drugs EMPAGLIFLOZIN\LINAGLIPTIN Demographics EMPAGLIFLOZIN\LINAGLIPTIN Timeline